{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:18:38Z","timestamp":1784204318952,"version":"3.55.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"DOI":"10.1007\/s00423-025-03778-6","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T11:35:39Z","timestamp":1757504139000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Is there a chance for curative treatment for metastatic pancreatic adenocarcinoma? A systematic review with meta-analysis"],"prefix":"10.1007","volume":"410","author":[{"given":"Kellil","family":"Tarek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tormane Mohamed","family":"Amine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhaiem","family":"Rami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amara","family":"Amal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianpaoli","family":"Francesca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanchez","family":"Stephane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piardi","family":"Tullio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"issue":"6","key":"3778_CR1","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin Nov 68(6):394\u2013424","journal-title":"CA Cancer J Clin Nov"},{"key":"3778_CR2","unstructured":"WCRF International [Internet] [2024] Cancer Prevention Organisation | World Cancer Research Fund International. Disponible sur: https:\/\/www.wcrf.org\/"},{"issue":"6","key":"3778_CR3","first-page":"977","volume":"155","author":"M Bockhorn","year":"2014","unstructured":"Bockhorn M, Uzunoglu FG, Adham M, Imrie C, Milicevic M, Sandberg AA et al (2014) Borderline resectable pancreatic cancer: A consensus statement by the international study group of pancreatic surgery (ISGPS). Surg 1 Juin 155(6):977\u2013988","journal-title":"Surg 1 Juin"},{"key":"3778_CR4","unstructured":"Cancer Facts & Figs (2022) | American Cancer Society [Internet] [cit\u00e9 1 juill 2024] Disponible sur: https:\/\/www.cancer.org\/research\/cancer-facts-statistics\/all-cancer-facts-figures\/cancer-facts-figures-2022.html"},{"key":"3778_CR5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.suronc.2020.08.005","volume":"35","author":"C Schwarz","year":"2020","unstructured":"Schwarz C, Fitschek F, Primavesi F, St\u00e4ttner S, Margonis GA, Weiss MA et al (2020) Metachronous hepatic resection for liver only pancreatic metastases. Surg Oncol 1 D\u00e9c 35:169\u2013173","journal-title":"Surg Oncol 1 D\u00e9c"},{"issue":"1","key":"3778_CR6","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s12957-020-02058-5","volume":"18","author":"Y Mitsuka","year":"2020","unstructured":"Mitsuka Y, Yamazaki S, Yoshida N, Yan M, Higaki T, Takayama T (2020) Time interval-based indication for liver resection of metastasis from pancreatic cancer. World J Surg Onc 10 Nov 18(1):294","journal-title":"World J Surg Onc 10 Nov"},{"issue":"9","key":"3778_CR7","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1007\/s11605-012-1912-8","volume":"16","author":"RM Thomas","year":"2012","unstructured":"Thomas RM, Truty MJ, Nogueras-Gonzalez GM, Fleming JB, Vauthey JN, Pisters PWT et al (2012) Selective reoperation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resection. J Gastrointest Surg 1 Sept 16(9):1696\u20131704","journal-title":"J Gastrointest Surg 1 Sept"},{"key":"3778_CR8","doi-asserted-by":"crossref","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919","DOI":"10.1136\/bmj.i4919"},{"issue":"6","key":"3778_CR9","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1097\/MPA.0000000000000365","volume":"44","author":"M Bahra","year":"2015","unstructured":"Bahra M, Pratschke J, Klein F, Neuhaus P, Boas-Knoop S, Puhl G et al (2015) Cytoreductive surgery for pancreatic Cancer improves overall outcome of Gemcitabine-Based chemotherapy. Pancreas Ao\u00fbt 44(6):930","journal-title":"Pancreas Ao\u00fbt"},{"issue":"1","key":"3778_CR10","first-page":"939350","volume":"2012","author":"F Klein","year":"2012","unstructured":"Klein F, Puhl G, Guckelberger O, Pelzer U, Pullankavumkal JR, Guel S et al (2012) The impact of simultaneous liver resection for occult liver metastases of pancreatic adenocarcinoma. Gastroenterol Res Pract 2012(1):939350","journal-title":"Gastroenterol Res Pract"},{"issue":"1","key":"3778_CR11","doi-asserted-by":"publisher","first-page":"100388","DOI":"10.1016\/j.esmoop.2022.100388","volume":"7","author":"SF Kruger","year":"2022","unstructured":"Kruger SF, Lohneis A, Abendroth A, Berger AW, Ettrich TJ, Waidmann O et al (2022) Prognosis and tumor biology of pancreatic cancer patients with isolated lung metastases: translational results from the German multicenter AIO-YMO-PAK-0515 study. ESMO Open 1 F\u00e9vr 7(1):100388","journal-title":"ESMO Open 1 F\u00e9vr"},{"issue":"3","key":"3778_CR12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1177\/03008916221110265","volume":"109","author":"W Lu","year":"2023","unstructured":"Lu W, Wang L, Lou J, Tang K (2023) Sequential therapy for pancreatic cancer patients with synchronous oligo-hepatic metastatic lesions. Tumori 1 Juin 109(3):307\u2013313","journal-title":"Tumori 1 Juin"},{"issue":"1","key":"3778_CR13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12893-021-01236-w","volume":"21","author":"T Mashiko","year":"2021","unstructured":"Mashiko T, Nakano A, Masuoka Y, Yamamoto S, Ozawa S, Nakagohri T (2021) Significance of pulmonary resection in patients with metachronous pulmonary metastasis from pancreatic ductal adenocarcinoma: a retrospective cohort study. BMC Surg 5 Mai 21(1):237","journal-title":"BMC Surg 5 Mai"},{"issue":"11","key":"3778_CR14","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1007\/s00595-023-02701-0","volume":"53","author":"Y Miyashita","year":"2023","unstructured":"Miyashita Y, Ose N, Okami J, Takami K, Sakamaki Y, Ikeda N et al (2023) Outcomes of surgical resection for pulmonary metastasis from pancreatic cancer. Surg Today 1 Nov 53(11):1236\u20131246","journal-title":"Surg Today 1 Nov"},{"key":"3778_CR15","doi-asserted-by":"crossref","unstructured":"Oweira H, Petrausch U, Helbling D, Schmidt J, Mannhart M, Mehrabi A et al (2017) Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis. World J Gastroenterol 23(10):1872\u201380","DOI":"10.3748\/wjg.v23.i10.1872"},{"issue":"10","key":"3778_CR16","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1007\/s10147-021-01961-5","volume":"26","author":"SA Safi","year":"2021","unstructured":"Safi SA, Fluegen G, Rehders A, Haeberle L, Fung S, Keitel V et al (2021) Surgical margin clearance and extended chemotherapy defines survival for synchronous oligometastatic liver lesions of the ductal adenocarcinoma of the pancreas. Int J Clin Oncol 1 Oct 26(10):1911\u20131921","journal-title":"Int J Clin Oncol 1 Oct"},{"issue":"1","key":"3778_CR17","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1245\/s10434-006-9131-8","volume":"14","author":"SV Shrikhande","year":"2007","unstructured":"Shrikhande SV, Kleeff J, Reiser C, Weitz J, Hinz U, Esposito I et al (2007) Pancreatic resection for M1 pancreatic ductal adenocarcinoma. Ann Surg Oncol 1 Janv 14(1):118\u2013127","journal-title":"Ann Surg Oncol 1 Janv"},{"issue":"1","key":"3778_CR18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/jhbp.1352","volume":"31","author":"WG Yun","year":"2024","unstructured":"Yun WG, Han Y, Lee M, Cho YJ, Jung HS, Kwon W et al (2024) Efficacy of local treatment for isolated liver metastasis after pancreatectomy in pancreatic ductal adenocarcinoma: A propensity score-matched analysis. J Hepato-Biliary- Pancreat Sci 31(1):50\u201360","journal-title":"J Hepato-Biliary- Pancreat Sci"},{"issue":"11","key":"3778_CR19","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1007\/s11605-016-3256-2","volume":"20","author":"GP Wright","year":"2016","unstructured":"Wright GP, Poruk KE, Zenati MS, Steve J, Bahary N, Hogg ME et al (2016) Primary tumor resection following favorable response to systemic chemotherapy in stage IV pancreatic adenocarcinoma with synchronous metastases: a Bi-institutional analysis. J Gastrointest Surg 1 Nov 20(11):1830\u20131835","journal-title":"J Gastrointest Surg 1 Nov"},{"key":"3778_CR20","doi-asserted-by":"publisher","unstructured":"Yao ZX, Tu JH, Zhou B, Huang Y, Liu YL, Xue XF (2022) Risk factors and survival prediction of pancreatic cancer with lung metastases: A population-based study. Front Oncol [cit\u00e9 1 juill 2024];12. Disponible sur: https:\/\/www.frontiersin.org\/journals\/oncology\/articles\/https:\/\/doi.org\/10.3389\/fonc.2022.952531\/full","DOI":"10.3389\/fonc.2022.952531\/full"},{"issue":"3\u20134","key":"3778_CR21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1159\/000313532","volume":"44","author":"F D\u00fcnschede","year":"2010","unstructured":"D\u00fcnschede F, Will L, von Langsdorf C, M\u00f6hler M, Galle PR, Otto G et al (2010) Treatment of metachronous and simultaneous liver metastases of pancreatic cancer. Eur Surg Res 1 Janv 44(3\u20134):209\u2013213","journal-title":"Eur Surg Res 1 Janv"},{"key":"3778_CR22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.suronc.2019.08.010","volume":"31","author":"M Ilmer","year":"2019","unstructured":"Ilmer M, Schiergens TS, Renz BW, Schneider C, Sargut M, Waligora R et al (2019) Oligometastatic pulmonary metastasis in pancreatic cancer patients: safety and outcome of resection. Surg Oncol 1 D\u00e9c 31:16\u201321","journal-title":"Surg Oncol 1 D\u00e9c"},{"issue":"5","key":"3778_CR23","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.21037\/tcr.2020.04.02","volume":"9","author":"C Wu","year":"2020","unstructured":"Wu C, Zhang X, Wang T, Zhou H, Guo C, Chen Y et al (2020) Primary tumor resection and lymph node dissection improve survival in de Novo metastatic pancreatic ductal adenocarcinoma: an inverse probability of treatment weighting analysis. Transl Cancer Res Mai 9(5):3312\u20133323","journal-title":"Transl Cancer Res Mai"},{"issue":"6","key":"3778_CR24","first-page":"1464","volume":"171","author":"A Hamad","year":"2022","unstructured":"Hamad A, Underhill J, Ansari A, Thayaparan V, Cloyd JM, Li Y et al (2022) Surgical treatment of hepatic oligometastatic pancreatic ductal adenocarcinoma: an analysis of the National Cancer database. Surg 1 Juin 171(6):1464\u20131470","journal-title":"Surg 1 Juin"},{"issue":"2","key":"3778_CR25","doi-asserted-by":"publisher","first-page":"539","DOI":"10.7150\/jca.51218","volume":"12","author":"BB Su","year":"2021","unstructured":"Su BB, Bai DS, Yu JQ, Zhang C, Jin SJ, Zhou BH et al (2021) Can patients with pancreatic Cancer and liver metastases obtain survival benefit from surgery?? A Population-Based study. J Cancer 1 Janv 12(2):539\u2013552","journal-title":"J Cancer 1 Janv"},{"issue":"5","key":"3778_CR26","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/jhbp.1127","volume":"29","author":"Y Homma","year":"2022","unstructured":"Homma Y, Endo I, Matsuyama R, Sho M, Mizuno S, Seyama Y et al (2022) Outcomes of lung metastasis from pancreatic cancer: A nationwide multicenter analysis. J Hepato-Biliary-Pancreat Sci 29(5):552\u2013561","journal-title":"J Hepato-Biliary-Pancreat Sci"},{"key":"3778_CR27","doi-asserted-by":"crossref","unstructured":"Crippa S, Bittoni A, Sebastiani E, Partelli S, Zanon S, Lanese A et al (2016) Is there a role for surgical resection in patients with pancreatic cancer with liver metastases responding to chemotherapy? Eur J Surg Oncol (EJSO) 42(10):1","DOI":"10.1016\/j.ejso.2016.06.398"},{"issue":"1","key":"3778_CR28","first-page":"136","volume":"160","author":"M Tachezy","year":"2016","unstructured":"Tachezy M, Gebauer F, Janot M, Uhl W, Zerbi A, Montorsi M et al (2016) Synchronous resections of hepatic oligometastatic pancreatic cancer: disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis. Surg 1 Juill 160(1):136\u2013144","journal-title":"Surg 1 Juill"},{"issue":"7","key":"3778_CR29","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/bjs.11144","volume":"106","author":"YI Kim","year":"2019","unstructured":"Kim YI, Song KB, Lee YJ, Park KM, Hwang DW, Lee JH et al (2019) Management of isolated recurrence after surgery for pancreatic adenocarcinoma. BJS (British J Surgery) 106(7):898\u2013909","journal-title":"BJS (British J Surgery)"},{"issue":"1","key":"3778_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.hpb.2019.05.015","volume":"22","author":"J Yang","year":"2020","unstructured":"Yang J, Zhang J, Lui W, Huo Y, Fu X, Yang M et al (2020) Patients with hepatic oligometastatic pancreatic body\/tail ductal adenocarcinoma May benefit from synchronous resection. HPB 1 Janv 22(1):91\u2013101","journal-title":"HPB 1 Janv"},{"key":"3778_CR31","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.amsu.2020.11.037","volume":"62","author":"Y Shao","year":"2021","unstructured":"Shao Y, Feng J, Hu Z, Wu J, Zhang M, Shen Y et al (2021) Feasibility of pancreaticoduodenectomy with synchronous liver metastasectomy for oligometastatic pancreatic ductal adenocarcinoma - A case-control study. Annals Med Surg F\u00e9vr 62:490","journal-title":"Annals Med Surg F\u00e9vr"},{"issue":"3","key":"3778_CR32","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3348\/kjr.2019.0647","volume":"21","author":"SJ Lee","year":"2020","unstructured":"Lee SJ, Kim JH, Kim SY, Won HJ, Shin YM, Kim PN (2020) Percutaneous radiofrequency ablation for metachronous hepatic metastases after curative resection of pancreatic adenocarcinoma. Korean J Radiol Mars 21(3):316\u2013324","journal-title":"Korean J Radiol Mars"},{"issue":"1","key":"3778_CR33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/cancers14010057","volume":"14","author":"TM Pausch","year":"2022","unstructured":"Pausch TM, Liu X, Cui J, Wei J, Miao Y, Heger U et al (2022) Survival benefit of resection surgery for pancreatic ductal adenocarcinoma with liver metastases: A propensity Score-Matched SEER database analysis. Cancers Janv 14(1):57","journal-title":"Cancers Janv"},{"issue":"9","key":"3778_CR34","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s11605-011-1605-8","volume":"15","author":"GJ Arnaoutakis","year":"2011","unstructured":"Arnaoutakis GJ, Rangachari D, Laheru DA, Iacobuzio-Donahue CA, Hruban RH, Herman JM et al (2011) Pulmonary resection for isolated pancreatic adenocarcinoma metastasis: an analysis of outcomes and survival. J Gastrointest Surg 1 Sept 15(9):1611\u20131617","journal-title":"J Gastrointest Surg 1 Sept"},{"key":"3778_CR35","doi-asserted-by":"crossref","unstructured":"Yun WG, Kwon W, Han Y, Sohn HJ, Kim HS, Lee M et al (2022) Can surgical resection of metastatic lesions be beneficial to pancreatic ductal adenocarcinoma patients with isolated lung metastasis? Cancers Janv 14(9):2067","DOI":"10.3390\/cancers14092067"},{"issue":"1","key":"3778_CR36","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1089\/pancan.2018.0011","volume":"4","author":"P Kandel","year":"2018","unstructured":"Kandel P, Wallace MB, Stauffer J, Bolan C, Raimondo M, Woodward TA et al (2018) Survival of patients with oligometastatic pancreatic ductal adenocarcinoma treated with combined modality treatment including surgical resection: A pilot study. J Pancreat Cancer 1 Janv 4(1):88\u201394","journal-title":"J Pancreat Cancer 1 Janv"},{"issue":"8","key":"3778_CR37","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.ejso.2019.03.039","volume":"45","author":"M Tanaka","year":"2019","unstructured":"Tanaka M, Heckler M, Mihaljevic AL, Sun H, Klaiber U, Heger U et al (2019) CT response of primary tumor and CA19-9 predict resectability of metastasized pancreatic cancer after FOLFIRINOX. Eur J Surg Oncol 1 Ao\u00fbt 45(8):1453\u20131459","journal-title":"Eur J Surg Oncol 1 Ao\u00fbt"},{"issue":"9","key":"3778_CR38","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/jhbp.648","volume":"26","author":"Y Byun","year":"2019","unstructured":"Byun Y, Han Y, Kang JS, Choi YJ, Kim H, Kwon W et al (2019) Role of surgical resection in the era of FOLFIRINOX for advanced pancreatic cancer. J Hepato-Biliary- Pancreat Sci 26(9):416\u2013425","journal-title":"J Hepato-Biliary- Pancreat Sci"},{"issue":"2","key":"3778_CR39","doi-asserted-by":"publisher","first-page":"319","DOI":"10.21037\/jgo.2020.03.02","volume":"11","author":"J Gu","year":"2020","unstructured":"Gu J, Xu Z, Ma Y, Chen H, Wang D, Deng X et al (2020) Surgical resection of metastatic pancreatic cancer: is it worth it?\u2014a 15-year experience at a single Chinese center. J Gastrointest Oncol Avr 11(2):319\u2013328","journal-title":"J Gastrointest Oncol Avr"},{"issue":"5","key":"3778_CR40","doi-asserted-by":"publisher","first-page":"e1089","DOI":"10.1097\/SLA.0000000000005481","volume":"277","author":"T Hank","year":"2023","unstructured":"Hank T, Klaiber U, Hinz U, Sch\u00fctte D, Leonhardt CS, Bergmann F et al (2023) Oncological outcome of conversion surgery after preoperative chemotherapy for metastatic pancreatic Cancer. Annals Surg Mai 277(5):e1089","journal-title":"Annals Surg Mai"},{"issue":"10242","key":"3778_CR41","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi JD, Surana R, Valle JW, Shroff RT (2020) Pancreatic cancer. Lancet 27 Juin 395(10242):2008\u20132020","journal-title":"Lancet 27 Juin"},{"key":"3778_CR42","doi-asserted-by":"publisher","first-page":"v318","DOI":"10.1093\/annonc\/mdz247.154","volume":"30","author":"M Wei","year":"2019","unstructured":"Wei M, Shi S, Xu J, Shen B, Mou Y, Qin R et al (2019) 828TiP - Simultaneous resection of pancreatic cancer and liver oligometastases after induction chemotherapy in stage IV patients: an open-label prospective randomized multicenter phase III trial (CSPAC-1). Annals Oncol 1 Oct 30:v318","journal-title":"Annals Oncol 1 Oct"},{"issue":"24","key":"3778_CR43","doi-asserted-by":"publisher","first-page":"5881","DOI":"10.3390\/cancers15245881","volume":"15","author":"IL Wahler","year":"2023","unstructured":"Wahler IL, Damanakis A, Gro\u00dfe Hokamp N, Bruns C, Schmidt T (2023) Therapy of locally advanced and oligometastatic pancreatic adenocarcinoma. Cancers (Basel) 1 D\u00e9c 15(24):5881","journal-title":"Cancers (Basel) 1 D\u00e9c"},{"key":"3778_CR44","doi-asserted-by":"crossref","unstructured":"Omiya K, Maekawa A, Oba A, Inoue Y, Hirose Y, Kobayashi K et al (2024) A proposal of ABCD metastasectomy criteria for synchronous\/metachronous metastatic pancreatic cancer in the era of multidisciplinary treatment. Br J Surg 111(1):znad417","DOI":"10.1093\/bjs\/znad417"},{"issue":"13","key":"3778_CR45","doi-asserted-by":"publisher","first-page":"8503","DOI":"10.1245\/s10434-022-12385-4","volume":"29","author":"I Frigerio","year":"2022","unstructured":"Frigerio I, Malleo G, de Pastena M, Deiro G, Surci N, Scopelliti F et al (2022) Prognostic factors after pancreatectomy for pancreatic Cancer initially metastatic to the liver. Ann Surg Oncol 1 D\u00e9c 29(13):8503\u20138510","journal-title":"Ann Surg Oncol 1 D\u00e9c"},{"key":"3778_CR46","doi-asserted-by":"crossref","unstructured":"Wainberg ZA, Melisi D, Macarulla T, Pazo Cid R, Chandana SR, De La Fouchardi\u00e8re C et al (2023) NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial. Lancet 7(10409):1272\u20131281","DOI":"10.1016\/S0140-6736(23)01366-1"},{"issue":"13","key":"3778_CR47","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1200\/JCO.19.02931","volume":"38","author":"EM O\u2019Reilly","year":"2020","unstructured":"O\u2019Reilly EM, Lee JW, Zalupski M, Capanu M, Park J, Golan T et al (2020) Randomized, multicenter, phase II trial of gemcitabine and cisplatin with or without veliparib in patients with pancreas adenocarcinoma and a germline BRCA\/PALB2 mutation. JCO Mai 38(13):1378\u20131388","journal-title":"JCO Mai"},{"issue":"1","key":"3778_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41698-023-00492-8","volume":"8","author":"A Yousef","year":"2024","unstructured":"Yousef A, Yousef M, Chowdhury S, Abdilleh K, Knafl M, Edelkamp P et al (2024) Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma. Npj Precis Onc 3 F\u00e9vr 8(1):1\u201313","journal-title":"Npj Precis Onc 3 F\u00e9vr"},{"issue":"2","key":"3778_CR49","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ejso.2016.10.023","volume":"43","author":"T Hackert","year":"2017","unstructured":"Hackert T, Niesen W, Hinz U, Tjaden C, Strobel O, Ulrich A et al (2017) Radical surgery of oligometastatic pancreatic cancer. Eur J Surg Oncol (EJSO) 1 F\u00e9vr 43(2):358\u2013363","journal-title":"Eur J Surg Oncol (EJSO) 1 F\u00e9vr"},{"issue":"45","key":"3778_CR50","doi-asserted-by":"publisher","first-page":"10024","DOI":"10.3748\/wjg.v22.i45.10024","volume":"22","author":"HJ Shi","year":"2016","unstructured":"Shi HJ, Jin C, Fu DL (2016) Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: diagnosis and assessment of unresectability. World J Gastroenterol 7 D\u00e9c 22(45):10024\u201310037","journal-title":"World J Gastroenterol 7 D\u00e9c"},{"issue":"1","key":"3778_CR51","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s13304-015-0283-6","volume":"67","author":"N Zanini","year":"2015","unstructured":"Zanini N, Lombardi R, Masetti M, Giordano M, Landolfo G, Jovine E (2015) Surgery for isolated liver metastases from pancreatic cancer. Updates Surg 1 Mars 67(1):19\u201325","journal-title":"Updates Surg 1 Mars"},{"issue":"11","key":"3778_CR52","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1002\/cncr.23074","volume":"110","author":"AL Gleisner","year":"2007","unstructured":"Gleisner AL, Assumpcao L, Cameron JL, Wolfgang CL, Choti MA, Herman JM et al (2007) Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified. Cancer 1 D\u00e9c 110(11):2484\u20132492","journal-title":"Cancer 1 D\u00e9c"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-025-03778-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00423-025-03778-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-025-03778-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T13:02:02Z","timestamp":1757509322000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00423-025-03778-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3778"],"URL":"https:\/\/doi.org\/10.1007\/s00423-025-03778-6","relation":{},"ISSN":["1435-2451"],"issn-type":[{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,10]]},"assertion":[{"value":"28 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"269"}}